These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24368416)

  • 1. Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth type 2D mice.
    Sleigh JN; Grice SJ; Burgess RW; Talbot K; Cader MZ
    Hum Mol Genet; 2014 May; 23(10):2639-50. PubMed ID: 24368416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic Deficits at Neuromuscular Junctions in Two Mouse Models of Charcot-Marie-Tooth Type 2d.
    Spaulding EL; Sleigh JN; Morelli KH; Pinter MJ; Burgess RW; Seburn KL
    J Neurosci; 2016 Mar; 36(11):3254-67. PubMed ID: 26985035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model.
    Seburn KL; Nangle LA; Cox GA; Schimmel P; Burgess RW
    Neuron; 2006 Sep; 51(6):715-26. PubMed ID: 16982418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HDAC6 is a therapeutic target in mutant GARS-induced Charcot-Marie-Tooth disease.
    Benoy V; Van Helleputte L; Prior R; d'Ydewalle C; Haeck W; Geens N; Scheveneels W; Schevenels B; Cader MZ; Talbot K; Kozikowski AP; Vanden Berghe P; Van Damme P; Robberecht W; Van Den Bosch L
    Brain; 2018 Mar; 141(3):673-687. PubMed ID: 29415205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant, toxic gain-of-function mutations in gars lead to non-cell autonomous neuropathology.
    Grice SJ; Sleigh JN; Motley WW; Liu JL; Burgess RW; Talbot K; Cader MZ
    Hum Mol Genet; 2015 Aug; 24(15):4397-406. PubMed ID: 25972375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase.
    He W; Bai G; Zhou H; Wei N; White NM; Lauer J; Liu H; Shi Y; Dumitru CD; Lettieri K; Shubayev V; Jordanova A; Guergueltcheva V; Griffin PR; Burgess RW; Pfaff SL; Yang XL
    Nature; 2015 Oct; 526(7575):710-4. PubMed ID: 26503042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental demands contribute to early neuromuscular degeneration in CMT2D mice.
    Sleigh JN; Mech AM; Schiavo G
    Cell Death Dis; 2020 Jul; 11(7):564. PubMed ID: 32703932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel adenoviral vector-mediated mouse model of Charcot-Marie-Tooth type 2D (CMT2D).
    Seo AJ; Shin YH; Lee SJ; Kim D; Park BS; Kim S; Choi KH; Jeong NY; Park C; Jang JY; Huh Y; Jung J
    J Mol Histol; 2014 Apr; 45(2):121-8. PubMed ID: 23990368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.
    Achilli F; Bros-Facer V; Williams HP; Banks GT; AlQatari M; Chia R; Tucci V; Groves M; Nickols CD; Seburn KL; Kendall R; Cader MZ; Talbot K; van Minnen J; Burgess RW; Brandner S; Martin JE; Koltzenburg M; Greensmith L; Nolan PM; Fisher EM
    Dis Model Mech; 2009; 2(7-8):359-73. PubMed ID: 19470612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired protein translation in Drosophila models for Charcot-Marie-Tooth neuropathy caused by mutant tRNA synthetases.
    Niehues S; Bussmann J; Steffes G; Erdmann I; Köhrer C; Sun L; Wagner M; Schäfer K; Wang G; Koerdt SN; Stum M; Jaiswal S; RajBhandary UL; Thomas U; Aberle H; Burgess RW; Yang XL; Dieterich D; Storkebaum E
    Nat Commun; 2015 Jul; 6():7520. PubMed ID: 26138142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels.
    Motley WW; Seburn KL; Nawaz MH; Miers KE; Cheng J; Antonellis A; Green ED; Talbot K; Yang XL; Fischbeck KH; Burgess RW
    PLoS Genet; 2011 Dec; 7(12):e1002399. PubMed ID: 22144914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by
    Sleigh JN; Dawes JM; West SJ; Wei N; Spaulding EL; Gómez-Martín A; Zhang Q; Burgess RW; Cader MZ; Talbot K; Yang XL; Bennett DL; Schiavo G
    Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3324-E3333. PubMed ID: 28351971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations.
    Stum M; McLaughlin HM; Kleinbrink EL; Miers KE; Ackerman SL; Seburn KL; Antonellis A; Burgess RW
    Mol Cell Neurosci; 2011 Feb; 46(2):432-43. PubMed ID: 21115117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphological analysis of neuromuscular junction development and degeneration in rodent lumbrical muscles.
    Sleigh JN; Burgess RW; Gillingwater TH; Cader MZ
    J Neurosci Methods; 2014 Apr; 227():159-65. PubMed ID: 24530702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations.
    Griffin LB; Sakaguchi R; McGuigan D; Gonzalez MA; Searby C; Züchner S; Hou YM; Antonellis A
    Hum Mutat; 2014 Nov; 35(11):1363-71. PubMed ID: 25168514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plexin-Semaphorin Signaling Modifies Neuromuscular Defects in a
    Grice SJ; Sleigh JN; Zameel Cader M
    Front Mol Neurosci; 2018; 11():55. PubMed ID: 29520219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered Sensory Neuron Development in CMT2D Mice Is Site-Specific and Linked to Increased GlyRS Levels.
    Sleigh JN; Mech AM; Aktar T; Zhang Y; Schiavo G
    Front Cell Neurosci; 2020; 14():232. PubMed ID: 32848623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIRT2-knockdown rescues GARS-induced Charcot-Marie-Tooth neuropathy.
    Zhao Y; Xie L; Shen C; Qi Q; Qin Y; Xing J; Zhou D; Qi Y; Yan Z; Lin X; Dai R; Lin J; Yu W
    Aging Cell; 2021 Jun; 20(6):e13391. PubMed ID: 34053152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in the GARS gene in a Malian family with Charcot-Marie-Tooth disease.
    Yalcouyé A; Diallo SH; Coulibaly T; Cissé L; Diallo S; Samassékou O; Diarra S; Coulibaly D; Keita M; Guinto CO; Fischbeck K; Landouré G;
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00782. PubMed ID: 31173493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant GlyRS-HDAC6 interaction linked to axonal transport deficits in Charcot-Marie-Tooth neuropathy.
    Mo Z; Zhao X; Liu H; Hu Q; Chen XQ; Pham J; Wei N; Liu Z; Zhou J; Burgess RW; Pfaff SL; Caskey CT; Wu C; Bai G; Yang XL
    Nat Commun; 2018 Mar; 9(1):1007. PubMed ID: 29520015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.